ArticleESMO open2016

Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacy.

Andrea Milani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.